Late Complications Following the Fontan Operation

Diagnosis and Management of Adult Congenital Heart Disease

Volumn , Issue , 2011, Pages 104-109

  Khairy, Paul ^a,b,c,d   Mercier, Lise Andrée ^a,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b Department of Medicine ^*  (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869828387     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3426-8.00012-5     Document Type: Chapter

References (30)

1. Khairy P., Poirier N., Mercier L.A. Univentricular heart. Circulation 2007, 115:800-812.
2. de Leval M.R., Kilner P., Gewillig M., Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. J Thorac Cardiovasc Surg 1988, 96:682-695.
3. Bridges N.D., Mayer J.E., Lock J.E., et al. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 1992, 86:1762-1769.
4. Norwood W.I. Hypoplastic left heart syndrome. Cardiol Clin 1989, 7:377-385.
5. de Leval M.R. The Fontan circulation: a challenge to William Harvey?. Nat Clin Pract Cardiovasc Med 2005, 2:202-208.
6. Magee A.G., McCrindle B.W., Mawson J., et al. Systemic venous collateral development after the bidirectional cavopulmonary anastomosis: prevalence and predictors. J Am Coll Cardiol 1998, 32:502-508.
7. O'Donnell C.P., Lock J.E., Powell A.J., Perry S.B. Compression of pulmonary veins between the left atrium and the descending aorta. Am J Cardiol 2003, 91:248-251.
8. Khairy P., Marelli A.J. Clinical use of electrocardiography in adults with congenital heart disease. Circulation 2007, 116:2734-2746.
9. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: Executive summary. J Am Coll Cardiol 2008, 52:1890-1947.
10. Khairy P., Fernandes S.M., Mayer J.E., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008, 117:85-92.
11. Weipert J., Noebauer C., Schreiber C., et al. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg 2004, 127:457-464.
12. Deal B.J., Mavroudis C., Backer C.L. Arrhythmia management in the Fontan patient. Pediatr Cardiol 2007, 28:448-456.
13. Triedman J.K., DeLucca J.M., Alexander M.E., et al. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm 2005, 2:700-705.
14. Triedman J.K., Alexander M.E., Love B.A., et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 2002, 39:1827-1835.
15. Mavroudis C., Deal B.J., Backer C.L. The beneficial effects of total cavopulmonary conversion and arrhythmia surgery for the failed Fontan. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002, 5:12-24.
16. Cohen M.I., Wernovsky G., Vetter V.L., et al. Sinus node function after a systematically staged Fontan procedure. Circulation 1998, 98:II352-II358.
17. Khairy P. EP challenges in adult congenital heart disease. Heart Rhythm 2008, 5:1464-1472.
18. Stephenson E.A., Batra A.S., Knilans T.K., et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006, 17:41-46.
19. Camposilvan S., Milanesi O., Stellin G., et al. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 2008, 86:177-182.
20. Ghaferi A.A., Hutchins G.M. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005, 129:1348-1352.
21. Kendall T.J., Stedman B., Hacking N., et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol 2008, 61:504-508.
22. Powell A.J., Gauvreau K., Jenkins K.J., et al. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure. Am J Cardiol 2001, 88:1206-1209.
23. Mertens L., Hagler D.J., Sauer U., et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998, 115:1063-1073.
24. Do T.B., Chu J.M., Berdjis F., Anas N.G. Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature. Pediatr Cardiol 2009, 30:352-355.
25. Ohuchi H., Yasuda K., Hasegawa S., et al. Influence of ventricular morphology on aerobic exercise capacity in patients after the Fontan operation. J Am Coll Cardiol 2001, 37:1967-1974.
26. Kouatli A.A., Garcia J.A., Zellers T.M., et al. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997, 96:1507-1512.
27. Khairy P., Ouyang D.W., Fernandes S.M., et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006, 113:517-524.
28. Canobbio M.M., Mair D.D., van der Velde M., Koos B.J. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996, 28:763-767.
29. Siu S.C., Sermer M., Colman J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001, 104:515-521.
30. Takahashi K., Fynn-Thompson F., Cecchin F., et al. Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Int J Cardiol 2009, 137:260-266.